Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Effectiveness of pneumococcal polysaccharide vaccine in older adults.

Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, Hanson CA, Mahoney LD, Shay DK, Thompson WW; Vaccine Safety Datalink.

N Engl J Med. 2003 May 1;348(18):1747-55.

2.
3.
4.

Pneumonia in the elderly.

Loeb M.

Curr Opin Infect Dis. 2004 Apr;17(2):127-30. Review.

PMID:
15021052
5.

Pneumococcal vaccine in the elderly: a useful but forgotten vaccine.

Chidiac C, Ader F.

Aging Clin Exp Res. 2009 Jun;21(3):222-8. Review.

PMID:
19571646
6.

Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.

Lynch JP 3rd, Zhanel GG.

Curr Opin Pulm Med. 2010 May;16(3):217-25. doi: 10.1097/MCP.0b013e3283385653. Review.

PMID:
20375783
7.

Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention.

Lynch JP 3rd, Zhanel GG.

Semin Respir Crit Care Med. 2009 Apr;30(2):189-209. doi: 10.1055/s-0029-1202938. Epub 2009 Mar 18. Review.

PMID:
19296419
8.

Pneumonia in older persons.

Loeb M.

Clin Infect Dis. 2003 Nov 15;37(10):1335-9. Epub 2003 Oct 13. Review.

PMID:
14583867
9.
10.

Burden of community-acquired pneumonia in North American adults.

File TM Jr, Marrie TJ.

Postgrad Med. 2010 Mar;122(2):130-41. doi: 10.3810/pgm.2010.03.2130. Review.

PMID:
20203464
11.
12.

[Prevention of community-acquired pneumonia in adults].

Barros M M, Cartagena S C, Bavestrello F L.

Rev Chilena Infectol. 2005;22 Suppl 1:s67-74. Epub 2005 Sep 13. Review. Spanish.

13.

[Pneumococcal infection is a vaccine-preventable disease now].

Tatochenko VK.

Zh Mikrobiol Epidemiol Immunobiol. 2010 May-Jun;(3):102-8. Review. Russian.

PMID:
20734728
14.

[Thousand faces of Streptococcus pneumonia (pneumococcus) infections].

Szabó BG, Lénárt KS, Kádár B, Gombos A, Dezsényi B, Szanka J, Bobek I, Prinz G.

Orv Hetil. 2015 Nov 1;156(44):1769-77. doi: 10.1556/650.2015.30293. Review. Hungarian.

PMID:
26498896
15.

Understanding the burden of pneumococcal disease in adults.

Blasi F, Mantero M, Santus P, Tarsia P.

Clin Microbiol Infect. 2012 Oct;18 Suppl 5:7-14. doi: 10.1111/j.1469-0691.2012.03937.x. Epub 2012 Aug 6. Review.

16.

Determining the contribution of <em>Streptococcus pneumoniae</em> to community-acquired pneumonia in Australia.

Yin JK, Jayasinghe SH, Charles PG, King C, Chiu CK, Menzies RI, McIntyre PB.

Med J Aust. 2017 Nov 6;207(9):396-400. Review.

PMID:
29092707
17.

Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview.

Vila-Corcoles A, Ochoa-Gondar O.

Expert Rev Vaccines. 2012 Feb;11(2):221-36. doi: 10.1586/erv.11.176. Review.

PMID:
22309670
18.

Pneumococcal conjugate vaccine use in adults.

Isturiz RE, Schmoele-Thoma B, Scott DA, Jodar L, Webber C, Sings HL, Paradiso P.

Expert Rev Vaccines. 2016;15(3):279-93. doi: 10.1586/14760584.2016.1132171. Epub 2015 Dec 29. Review.

PMID:
26651847
19.

Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines.

Principi N, Esposito S.

Int J Mol Sci. 2016 Dec 25;18(1). pii: E30. doi: 10.3390/ijms18010030. Review.

20.

Pneumococcal infections: association with asthma and COPD.

Obert J, Burgel PR.

Med Mal Infect. 2012 May;42(5):188-92. doi: 10.1016/j.medmal.2012.02.003. Epub 2012 Mar 22. Review.

PMID:
22444165

Supplemental Content

Support Center